방사선량 관리 시장 : 시장 규모, 점유율, 성장률, 산업 분석, 유형별, 용도별, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of radiation dose management Market

The global radiation dose management market is witnessing significant growth driven by rising imaging procedures, strict patient safety regulations, and increasing adoption of advanced radiology technologies. According to the 2025 report analysis, the market was valued at USD 854.2 million in 2025 and is projected to grow to USD 973.3 million in 2026. The market is expected to reach USD 3,004.00 million by 2034, expanding at a robust CAGR of 15.10% during 2026-2034.

North America dominated the global market with a 39.10% share in 2025, supported by strong regulatory frameworks, high imaging volumes, and early adoption of advanced dose monitoring software.

Market Overview

Radiation dose management refers to solutions and software systems designed to monitor, track, and optimize radiation exposure during medical imaging procedures such as CT scans, radiography, fluoroscopy, and nuclear medicine. These systems help healthcare providers maintain compliance with safety guidelines while ensuring high-quality diagnostic imaging.

The growing number of imaging procedures globally, combined with increasing awareness of radiation-related health risks, is a primary factor fueling demand for dose management solutions. Strategic collaborations among key industry players are further strengthening market expansion. For instance, partnerships between leading imaging companies and dose management solution providers are accelerating technological integration and workflow optimization.

COVID-19 Impact

The COVID-19 pandemic had a positive impact on the radiation dose management market. The surge in CT scans for diagnosing COVID-19 significantly increased imaging volumes worldwide. Since CT imaging involves ionizing radiation, hospitals increasingly adopted dose monitoring solutions to ensure patient safety and regulatory compliance.

Higher CT utilization led to increased sales of imaging equipment, which in turn drove demand for integrated radiation dose management software. The market fully recovered by 2022 and has since resumed strong growth momentum.

Key Market Trends

Integration of Artificial Intelligence (AI)

A major trend shaping the market is the integration of Artificial Intelligence (AI) in radiology. AI-powered algorithms help:

• Optimize imaging protocols
• Improve image reconstruction
• Predict patient-specific radiation doses
• Enhance risk prediction models

As AI continues to evolve, it is expected to further improve dose optimization strategies and support personalized imaging approaches, significantly strengthening market growth through 2034.

Market Growth Drivers

1. Stringent Radiation Safety Regulations

Global organizations such as the International Atomic Energy Agency (IAEA) and European regulatory bodies have established strict safety standards for ionizing radiation. Growing regulatory pressure to reduce unnecessary radiation exposure-especially among vulnerable populations such as pregnant women and children-is driving widespread adoption of dose management software.

2. Technological Advancements in Imaging

Continuous advancements in CT scanners, iterative reconstruction algorithms, and imaging software are improving image quality while reducing radiation exposure. Vendors are launching upgraded versions of dose management platforms with enhanced analytics and monitoring capabilities, accelerating market penetration.

Restraining Factors

Despite strong growth prospects, certain challenges persist:

• High costs associated with imaging systems and dose management software
• Limited healthcare infrastructure in low- and middle-income countries
• Budget constraints in smaller hospitals and diagnostic centers

In many developing regions, insufficient electricity supply and limited imaging facilities hinder large-scale adoption.

Market Segmentation Analysis

By Procedure

The market is segmented into:

• Computed Tomography (CT)
• Nuclear Medicine
• Radiography & Mammography
• Fluoroscopy & Interventional Imaging
• Others

The Radiography and Mammography segment held the largest share and is expected to account for 40.46% of the market in 2026, driven by rising X-ray and breast cancer screening procedures.

The Nuclear Medicine segment is projected to grow at the highest CAGR due to increasing PET and SPECT scan volumes globally.

By Application

Key application areas include:

• Oncology
• Orthopedics
• Cardiology
• Neurology
• Others

The Orthopedics segment held the largest share, accounting for 36.64% in 2026, supported by increasing trauma cases and sports injuries requiring fluoroscopic guidance.

The Oncology segment is anticipated to register the highest CAGR due to the growing need for repetitive CT scans for cancer diagnosis and monitoring.

By End User

The market is categorized into:

• Hospitals & Specialty Clinics
• Diagnostic Centers
• Others

The Diagnostic Centers segment dominated with a 49.60% share in 2026 and is expected to grow at the highest CAGR through 2034, driven by increasing outpatient imaging volumes.

Regional Insights

North America

North America generated USD 333.9 million in 2025, maintaining market leadership. The U.S. market is projected to reach USD 361 million in 2026. Growth is supported by high nuclear medicine procedure volumes and strong regulatory enforcement.

Europe

Europe held the second-largest share in 2025, driven by increasing radiation safety training and regulatory initiatives. Germany and the UK are major contributors to regional growth.

Asia Pacific

Asia Pacific is projected to grow at the highest CAGR through 2034. The region's growth is fueled by expanding healthcare infrastructure and rising healthcare expenditure.

• Japan market expected to reach USD 108.5 million in 2026
• China market projected at USD 85.7 million in 2026
• India market estimated at USD 42.3 million in 2026

Rest of the World

Growth remains comparatively slower due to limited infrastructure and lower healthcare spending.

Competitive Landscape

Major players operating in the radiation dose management market include:

• Siemens Healthineers AG
• FUJIFILM Corporation
• GE Healthcare
• Bayer AG
• Koninklijke Philips N.V.
• Bracco
• Medsquare SAS

These companies maintain strong positions through diversified product portfolios, technological innovation, strategic partnerships, and geographic expansion.

Conclusion

The global radiation dose management market is poised for strong expansion from USD 854.2 million in 2025 to USD 3,004.00 million by 2034, driven by increasing imaging volumes, AI integration, regulatory compliance requirements, and technological advancements. While cost and infrastructure challenges remain in developing regions, growing awareness of radiation safety and expanding diagnostic capabilities worldwide will continue to propel long-term market growth.

Segmentation By Procedure

• Computed Tomography
• Nuclear Medicine
• Radiography and Mammography
• Fluoroscopy and Interventional Imaging
• Others

By Application

• Oncology
• Orthopedics
• Cardiology
• Neurology
• Others

By End-user

• Hospitals & Specialty Clinics
• Diagnostic Centers
• Others

By Geography

• North America (By Procedure, By Application, By End-user, and By Country)
  • U.S.
  • Canada
• Europe (By Procedure, By Application, By End-user, and By Country/Sub-region)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Procedure, By Application, By End-user, and By Country/Sub-region)
  • China
  • India
  • Japan
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Rest of the World (By Procedure, By Application, and By End-user)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Number of Computed tomography (CT) Exams, Key Countries/ Regions, 2025
• 4.2. Number of Magnetic Resonance Imaging (MRI) Exams, Key Countries/ Regions, 2025
• 4.3. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, etc.)
• 4.4. Impact of COVID-19 in the Market

5. Global Radiation Dose Management Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Procedure
  • 5.1.1. Computed Tomography
  • 5.1.2. Nuclear Medicine
  • 5.1.3. Radiography and Mammography
  • 5.1.4. Fluoroscopy and Interventional Imaging
  • 5.1.5. Others
• 5.2. Market Analysis, Insights and Forecast - By Application
  • 5.2.1. Oncology
  • 5.2.2. Orthopedics
  • 5.2.3. Cardiology
  • 5.2.4. Neurology
  • 5.2.5. Others
• 5.3. Market Analysis, Insights and Forecast - By End-user
  • 5.3.1. Hospitals & Specialty Clinics
  • 5.3.2. Diagnostic Centers
  • 5.3.3. Others
• 5.4. Market Analysis, Insights and Forecast - By Region
  • 5.4.1. North America
  • 5.4.2. Europe
  • 5.4.3. Asia Pacific
  • 5.4.4. Latin America
  • 5.4.5. Middle East & Africa

6. North America Radiation Dose Management Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Procedure
  • 6.1.1. Computed Tomography
  • 6.1.2. Nuclear Medicine
  • 6.1.3. Radiography and Mammography
  • 6.1.4. Fluoroscopy and Interventional Imaging
  • 6.1.5. Others
• 6.2. Market Analysis, Insights and Forecast - By Application
  • 6.2.1. Oncology
  • 6.2.2. Orthopedics
  • 6.2.3. Cardiology
  • 6.2.4. Neurology
  • 6.2.5. Others
• 6.3. Market Analysis, Insights and Forecast - By End-user
  • 6.3.1. Hospitals & Specialty Clinics
  • 6.3.2. Diagnostic Centers
  • 6.3.3. Others
• 6.4. Market Analysis, Insights and Forecast - By Country
  • 6.4.1. U.S.
  • 6.4.2. Canada

7. Europe Radiation Dose Management Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Procedure
  • 7.1.1. Computed Tomography
  • 7.1.2. Nuclear Medicine
  • 7.1.3. Radiography and Mammography
  • 7.1.4. Fluoroscopy and Interventional Imaging
  • 7.1.5. Others
• 7.2. Market Analysis, Insights and Forecast - By Application
  • 7.2.1. Oncology
  • 7.2.2. Orthopedics
  • 7.2.3. Cardiology
  • 7.2.4. Neurology
  • 7.2.5. Others
• 7.3. Market Analysis, Insights and Forecast - By End-user
  • 7.3.1. Hospitals & Specialty Clinics
  • 7.3.2. Diagnostic Centers
  • 7.3.3. Others
• 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 7.4.1. U.K.
  • 7.4.2. Germany
  • 7.4.3. France
  • 7.4.4. Italy
  • 7.4.5. Spain
  • 7.4.6. Scandinavia
  • 7.4.7. Rest of Europe

8. Asia Pacific Radiation Dose Management Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Procedure
  • 8.1.1. Computed Tomography
  • 8.1.2. Nuclear Medicine
  • 8.1.3. Radiography and Mammography
  • 8.1.4. Fluoroscopy and Interventional Imaging
  • 8.1.5. Others
• 8.2. Market Analysis, Insights and Forecast - By Application
  • 8.2.1. Oncology
  • 8.2.2. Orthopedics
  • 8.2.3. Cardiology
  • 8.2.4. Neurology
  • 8.2.5. Others
• 8.3. Market Analysis, Insights and Forecast - By End-user
  • 8.3.1. Hospitals & Specialty Clinics
  • 8.3.2. Diagnostic Centers
  • 8.3.3. Others
• 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 8.4.1. Japan
  • 8.4.2. China
  • 8.4.3. India
  • 8.4.4. Australia
  • 8.4.5. Southeast Asia
  • 8.4.6. Rest of Asia Pacific

9. Latin America Radiation Dose Management Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Procedure
  • 9.1.1. Computed Tomography
  • 9.1.2. Nuclear Medicine
  • 9.1.3. Radiography and Mammography
  • 9.1.4. Fluoroscopy and Interventional Imaging
  • 9.1.5. Others
• 9.2. Market Analysis, Insights and Forecast - By Application
  • 9.2.1. Oncology
  • 9.2.2. Orthopedics
  • 9.2.3. Cardiology
  • 9.2.4. Neurology
  • 9.2.5. Others
• 9.3. Market Analysis, Insights and Forecast - By End-user
  • 9.3.1. Hospitals & Specialty Clinics
  • 9.3.2. Diagnostic Centers
  • 9.3.3. Others
• 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 9.4.1. Brazil
  • 9.4.2. Mexico
  • 9.4.3. Rest of Latin America

10. Middle East & Africa Radiation Dose Management Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Procedure
  • 10.1.1. Computed Tomography
  • 10.1.2. Nuclear Medicine
  • 10.1.3. Radiography and Mammography
  • 10.1.4. Fluoroscopy and Interventional Imaging
  • 10.1.5. Others
• 10.2. Market Analysis, Insights and Forecast - By Application
  • 10.2.1. Oncology
  • 10.2.2. Orthopedics
  • 10.2.3. Cardiology
  • 10.2.4. Neurology
  • 10.2.5. Others
• 10.3. Market Analysis, Insights and Forecast - By End-user
  • 10.3.1. Hospitals & Specialty Clinics
  • 10.3.2. Diagnostic Centers
  • 10.3.3. Others
• 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 10.4.1. GCC
  • 10.4.2. South Africa
  • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. Bayer AG
    • 11.2.1.1. Overview
    • 11.2.1.2. Product
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. financials (Based on Availability)
  • 11.2.2. Siemens Healthineers AG
    • 11.2.2.1. Overview
    • 11.2.2.2. Product
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. financials (Based on Availability)
  • 11.2.3. FUJIFILM Corporation
    • 11.2.3.1. Overview
    • 11.2.3.2. Product
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. financials (Based on Availability)
  • 11.2.4. GE Healthcare
    • 11.2.4.1. Overview
    • 11.2.4.2. Product
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. financials (Based on Availability)
  • 11.2.5. Koninklijke Philips N.V.
    • 11.2.5.1. Overview
    • 11.2.5.2. Product
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. financials (Based on Availability)
  • 11.2.6. Bracco
    • 11.2.6.1. Overview
    • 11.2.6.2. Product
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. financials (Based on Availability)
  • 11.2.7. Medsquare SAS
    • 11.2.7.1. Overview
    • 11.2.7.2. Product
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. financials (Based on Availability)